Research library
Compound reference index.
Every compound reference page in the Peptide Plug research library, A to Z. Each page covers regulatory status, published half-life and cautions. None of them tell you what dose to take.
All compounds (A–Z)
77 reference pages.
Compound
5-Amino-1mq
Regulatory status, published half-life (No robust published human PK data) and cautions.
Compound
Adipotide (Ftpp)
Regulatory status, published half-life and cautions.
Compound
Anastrozole
Regulatory status, published half-life (~46–50 hours) and cautions.
Compound
AOD-9604
Regulatory status, published half-life and cautions.
Compound
Argireline
Regulatory status, published half-life (Not applicable — topical cosmetic peptide) and cautions.
Compound
BPC-157
Regulatory status, published half-life and cautions.
Compound
Bpc-157 / Kpv Blend
Regulatory status, published half-life and cautions.
Compound
BPC-157 / TB-500 Blend
Regulatory status, published half-life and cautions.
Compound
Cagrilintide
Regulatory status, published half-life (~7–8 days (159–195h) and cautions.
Compound
Cagrilintide / Semaglutide Blend
Regulatory status, published half-life and cautions.
Compound
Cerebrolysin
Regulatory status, published half-life and cautions.
Compound
CJC-1295
Regulatory status, published half-life (~6–8 days (with DAC) and cautions.
Compound
CJC-1295 / Ipamorelin Blend
Regulatory status, published half-life and cautions.
Compound
CJC-1295 No DAC
Regulatory status, published half-life (~30 minutes) and cautions.
Compound
Clomiphene (Clomid)
Regulatory status, published half-life (~5–7 days (average) and cautions.
Compound
Dhea
Regulatory status, published half-life and cautions.
Compound
Dihexa
Regulatory status, published half-life and cautions.
Compound
Dsip (Delta Sleep-Inducing Peptide)
Regulatory status, published half-life and cautions.
Compound
Enclomiphene
Regulatory status, published half-life (~10 hours) and cautions.
Compound
Epithalon
Regulatory status, published half-life (Very short — minutes; rapidly degraded) and cautions.
Compound
Exemestane
Regulatory status, published half-life (~24 hours) and cautions.
Compound
Follistatin 344
Regulatory status, published half-life and cautions.
Compound
Foxo4-Dri
Regulatory status, published half-life and cautions.
Compound
GHK-Cu
Regulatory status, published half-life (Minutes — rapidly metabolized once in circulation) and cautions.
Compound
Ghk-Cu / Bpc-157 Blend
Regulatory status, published half-life and cautions.
Compound
Ghrp-2
Regulatory status, published half-life (~15–30 minutes) and cautions.
Compound
Ghrp-6
Regulatory status, published half-life (~10–60 minutes (commonly cited ~15–26 min) and cautions.
Compound
Glutathione
Regulatory status, published half-life and cautions.
Compound
Hcg (Human Chorionic Gonadotropin)
Regulatory status, published half-life (~24–32 hours) and cautions.
Compound
Hexarelin
Regulatory status, published half-life (~70–150 minutes depending on route) and cautions.
Compound
Hexarelin / Cjc-1295 Blend
Regulatory status, published half-life and cautions.
Compound
Hgh Fragment 176-191
Regulatory status, published half-life and cautions.
Compound
Hmg (Human Menopausal Gonadotropin)
Regulatory status, published half-life and cautions.
Compound
Humanin
Regulatory status, published half-life (No published human PK data) and cautions.
Compound
Igf-1 Lr3
Regulatory status, published half-life (~20–30 hours) and cautions.
Compound
Ipamorelin
Regulatory status, published half-life (~2 hours) and cautions.
Compound
Kisspeptin-10
Regulatory status, published half-life (~4 minutes) and cautions.
Compound
Kpv
Regulatory status, published half-life and cautions.
Compound
Letrozole
Regulatory status, published half-life (~2 days (terminal, longer with repeated dosing) and cautions.
Compound
Liraglutide
Regulatory status, published half-life (~13 hours) and cautions.
Compound
Ll-37
Regulatory status, published half-life and cautions.
Compound
Melanotan I
Regulatory status, published half-life and cautions.
Compound
Melanotan Ii
Regulatory status, published half-life (~30–45 minutes) and cautions.
Compound
Mgf (Mechano Growth Factor)
Regulatory status, published half-life and cautions.
Compound
Mk-677 (Ibutamoren)
Regulatory status, published half-life (~24 hours) and cautions.
Compound
MOTS-c
Regulatory status, published half-life (No robust human PK data — mostly preclinical) and cautions.
Compound
N-Acetyl Selank Amidate
Regulatory status, published half-life and cautions.
Compound
N-Acetyl Semax
Regulatory status, published half-life and cautions.
Compound
Nad+
Regulatory status, published half-life and cautions.
Compound
Noopept
Regulatory status, published half-life and cautions.
Compound
Oxytocin
Regulatory status, published half-life (~1–6 minutes) and cautions.
Compound
PT-141
Regulatory status, published half-life (~2.7 hours) and cautions.
Compound
Retatrutide
Regulatory status, published half-life (~5.5–6 days (130–140h) and cautions.
Compound
Selank
Regulatory status, published half-life (~20 minutes) and cautions.
Compound
Semaglutide
Regulatory status, published half-life (~7 days) and cautions.
Compound
Semax
Regulatory status, published half-life (~30 minutes (intranasal) and cautions.
Compound
Sermorelin
Regulatory status, published half-life (~10–20 minutes) and cautions.
Compound
Sermorelin / Ipamorelin Blend
Regulatory status, published half-life and cautions.
Compound
Snap-8
Regulatory status, published half-life and cautions.
Compound
SS-31
Regulatory status, published half-life (~1–5 hours (elamipretide, limited human data) and cautions.
Compound
Survodutide
Regulatory status, published half-life (~6 days) and cautions.
Compound
Sustanon (Testosterone Blend)
Regulatory status, published half-life and cautions.
Compound
Tamoxifen (Nolvadex)
Regulatory status, published half-life and cautions.
Compound
TB-500
Regulatory status, published half-life and cautions.
Compound
Tesamorelin
Regulatory status, published half-life (~26–38 minutes) and cautions.
Compound
Tesamorelin / Ipamorelin Blend
Regulatory status, published half-life and cautions.
Compound
Testosterone Cypionate
Regulatory status, published half-life (~8 days) and cautions.
Compound
Testosterone Cypionate / Hcg Blend
Regulatory status, published half-life and cautions.
Compound
Testosterone Enanthate
Regulatory status, published half-life (~4.5–8 days) and cautions.
Compound
Testosterone Propionate
Regulatory status, published half-life (~0.8 days (~19–24h) and cautions.
Compound
Testosterone Suspension
Regulatory status, published half-life (Hours (no ester) and cautions.
Compound
Testosterone Undecanoate
Regulatory status, published half-life (~20–34 days) and cautions.
Compound
Thymosin Alpha-1
Regulatory status, published half-life (~2 hours) and cautions.
Compound
Thymosin Beta-4
Regulatory status, published half-life (~2 hours (animal PK) and cautions.
Compound
Thymulin
Regulatory status, published half-life and cautions.
Compound
Tirzepatide
Regulatory status, published half-life (~5 days) and cautions.
Compound
Vip (Vasoactive Intestinal Peptide)
Regulatory status, published half-life (~1–2 minutes) and cautions.
Medication trackers
Free tracker pages for common GLP-1 and HRT medications.
Tracker
Semaglutide Tracker
Log semaglutide doses, sites and supply.
Tracker
Ozempic Tracker
Weekly injection and pen log.
Tracker
Wegovy Tracker
Dose, site and weight log.
Tracker
Tirzepatide Tracker
Log tirzepatide doses, sites and supply.
Tracker
Mounjaro Tracker
Weekly dose and site log.
Tracker
Zepbound Tracker
Log doses, sites and supply.
Tracker
Estradiol Tracker
HRT dose and symptom log.
Compare tracking apps
How Peptide Plug compares with other trackers.
Educational content, not medical advice. These reference pages summarise published status and half-life information. They do not recommend a dose, a schedule or a product. Those decisions belong to you and a licensed clinician.